The cleanser significantly increased skin hydration by +17% on D28 vs. D0 vs. the untreated area. In addition, all subjects appreciated the gentle cleansing and the ease of rinsing, and 95% appreciated the enveloping and creamy texture which avoids friction on the weakened area, and the remaining protective film. From the first application, they found their skin moisturized (95%), soothed (100%) and purified (100%). On D28, for 100% of them, their skin was soft and protected, with a restored skin comfort. Finally, the clinical trial with the cream shows significant decrease of scar color (-34%), scar pigmentation (-32%), thickness (-31%), vascularity (-49%), pliability (-46%), and VSS total score (-39%) at D14. In addition, a significant improvement of the skin lightness (+6%), redness (-23%), skin color homogeneity through delta E (-28%), and a decrease of scar marks was noticed, as well as the scar thickness at D14 vs. D0. For both products, the tolerance was very good.